AG
BSX icon

AIA Group’s Boston Scientific BSX Stock Holding History

AIA Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7M Buy
186,665
+28,690
+18% +$2.3M 0.17% 88
2025
Q4 		$15.1M Buy
157,975
+52,510
+50% +$5.15M 0.23% 62
2025
Q3 		$10.3M Sell
105,465
-8,790
-8% -$910K 0.18% 82
2025
Q2 		$12.3M Buy
114,255
+4,171
+4% +$422K 0.27% 49
2025
Q1 		$11.1M Buy
110,084
+13,772
+14% +$1.39M 0.27% 53
2024
Q4 		$8.6M Buy
96,312
+91,868
+2,067% +$8.09M 0.21% 55
2024
Q3 		$372K Sell
4,444
-687
-13% -$54.2K 0.01% 255
2024
Q2 		$395K Sell
5,131
-1,076
-17% -$78.8K 0.01% 251
2024
Q1 		$425K Sell
6,207
-16,110
-72% -$1.04M 0.01% 252
2023
Q4 		$1.29M Buy
22,317
+10,346
+86% +$552K 0.05% 171
2023
Q3 		$632K Buy
11,971
+2,174
+22% +$114K 0.03% 203
2023
Q2 		$530K Sell
9,797
-2,366
-19% -$124K 0.03% 236
2023
Q1 		$609K Buy
+12,163
New +$573K 0.03% 199
2022
Q2 		– Sell
-2,534
Closed -$112K – 467
2022
Q1 		$112K Sell
2,534
-40,456
-94% -$1.75M ﹤0.01% 457
2021
Q4 		$1.83M Buy
+42,990
New +$1.81M 0.09% 102

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AIA Group's BSX Position: Q1 2026 in Review

AIA Group increased its Boston Scientific (BSX) stake by 18% in Q1 2026, buying an estimated $2.3M and bringing the position to 186,665 shares worth $11.7M. The position accounts for 0.17% of the portfolio, ranked #88.

AIA Group first reported a position in BSX in Q4 2021 and has held it in 15 quarters since. The position peaked at $15.1M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • AIA Group held 186,665 shares of Boston Scientific worth $11.7M as of Q1 2026.
  • AIA Group bought 28,690 Boston Scientific shares in Q1 2026, an estimated $2.3M.
  • Boston Scientific made up 0.17% of AIA Group's portfolio in Q1 2026, its #88 holding.
  • AIA Group first reported a position in Boston Scientific in Q4 2021 and has held it in 15 quarters since.
  • AIA Group's Boston Scientific position peaked at $15.1M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.